MP13-04 ONABOTULINUMTOXINA IMPROVES IDIOPATHIC OVERACTIVE BLADDER SYMPTOMS IN PATIENTS REFRACTORY TO ORAL MEDICATIONS

MLA

Elisabeth Carlsson Farrelly, et al. “Mp13-04 Onabotulinumtoxina Improves Idiopathic Overactive Bladder Symptoms in Patients Refractory to Oral Medications.” Journal of Urology, vol. 207, May 2022. EBSCOhost, https://doi.org/10.1097/ju.0000000000002542.04.

APA

Elisabeth Carlsson Farrelly, Maria-Fernando Lorenzo-Gomez, Heinrich Schulte-Baukloh, Mariana Nelson, & Rizwan Hamid. (2022). Mp13-04 Onabotulinumtoxina Improves Idiopathic Overactive Bladder Symptoms in Patients Refractory to Oral Medications. Journal of Urology, 207. https://doi.org/10.1097/ju.0000000000002542.04

Chicago

Elisabeth Carlsson Farrelly, Maria-Fernando Lorenzo-Gomez, Heinrich Schulte-Baukloh, Mariana Nelson, and Rizwan Hamid. 2022. “Mp13-04 Onabotulinumtoxina Improves Idiopathic Overactive Bladder Symptoms in Patients Refractory to Oral Medications.” Journal of Urology 207 (May). doi:10.1097/ju.0000000000002542.04.